Continuing Medical Education: Neurology CME: Cognitive Dysfunction in Multiple Sclerosis: Techniques for Neuropsychological Assessment and Multimodal Therapy: CME Outfitters: Online: March 10, 2011 - March 10, 2012
http://www.cmenetworks.com/cme/11687/1/Continuing-Medical-Education-Neurology-CME-Cognitive-Dysfunction-in-Multiple-Sclerosis-Techniques-for-Neuropsychological-Assessment-and-Multimodal-Therapy-CME-Outfitters-Online-March-10-2011---March-10-2012/Page1.html
CME Outfitters
CME Outfitters is an independent accredited healthcare communications agency providing multidisciplinary continuing medical education content development, production, marketing, accreditation, and project management services to the healthcare industry.
By CME Outfitters
Published on 02/21/2011
Cognitive Dysfunction in Multiple Sclerosis: Techniques for Neuropsychological Assessment and Multimodal Therapy
CME Outfitters, LLC
March 10, 2011 - March 10, 2012
The goal of this activity is to address gaps in application of neuropsychological assessment techniques for cognitive dysfunction, and the integration of available, multimodal therapies into management plans for patients with MS to improve individualized care related to issues caused by cognitive impairment.
CME Sponsor:
CME Outfitters, LLC
Location: Online Activity
Course Directors/Instructors:
Moderator
Michael K. Racke, MD
Professor and Chairman in Neurology
The Helen C. Kurtz Chair in Neurology
Department of Neurology
Ohio State University Medical Center
Columbus, OH
Faculty Information
Aaron Boster, MD
Assistant Clinical Professor
Department of Neurology
Ohio State University
Columbus, OH
Number of Credits:
1.0 AMA PRA Category 1 Credit™
Registration Fee: Free
More Info
Detailed Description:
Cognitive dysfunction is a common feature of multiple sclerosis (MS) that frequently leads to impaired activities of daily living, social skills deficits, diminished social support, and unemployment. The direct link between cognitive impairment and lowered quality of life requires a call to action for clinicians to not only learn the evidence for routine assessment of cognitive dysfunction in MS, but also to gain competence in implementing evidence-based treatment strategies, using both nonpharmacologic modalities such as lifestyle and rehabilitation programs, and where benefits may exist, pharmacologic therapies. There is currently no FDA-approved pharmacological treatment for addressing cognitive deficits in MS, nor is there is an optimal nonpharmacological treatment strategy. Nevertheless, it is critical that clinicians be able to integrate routine neuropsychological testing and multimodal therapies in order to design the most appropriate individual treatment for their patients with MS. In this neuroscienceCME Chart Review, expert faculty will review a patient case focusing on assessment of cognitive dysfunction and strategies for multimodal therapy, thereby providing participants with best-practice tips for application into clinical practice.
Learning Objectives:
At the end of this CE activity, participants should be able to:
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other healthcare professionals with an interest in multiple sclerosis.
Cognitive Dysfunction in Multiple Sclerosis: Techniques for Neuropsychological Assessment and Multimodal Therapy
CME Outfitters, LLC
March 10, 2011 - March 10, 2012
The goal of this activity is to address gaps in application of neuropsychological assessment techniques for cognitive dysfunction, and the integration of available, multimodal therapies into management plans for patients with MS to improve individualized care related to issues caused by cognitive impairment.
Cognitive Dysfunction in Multiple Sclerosis: Techniques for Neuropsychological Assessment and Multimodal Therapy
CME Sponsor:
CME Outfitters, LLC
Location: Online Activity
Course Directors/Instructors:
Moderator
Michael K. Racke, MD
Professor and Chairman in Neurology
The Helen C. Kurtz Chair in Neurology
Department of Neurology
Ohio State University Medical Center
Columbus, OH
Faculty Information
Aaron Boster, MD
Assistant Clinical Professor
Department of Neurology
Ohio State University
Columbus, OH
Number of Credits:
1.0 AMA PRA Category 1 Credit™
Registration Fee: Free
More Info
Detailed Description:
Cognitive dysfunction is a common feature of multiple sclerosis (MS) that frequently leads to impaired activities of daily living, social skills deficits, diminished social support, and unemployment. The direct link between cognitive impairment and lowered quality of life requires a call to action for clinicians to not only learn the evidence for routine assessment of cognitive dysfunction in MS, but also to gain competence in implementing evidence-based treatment strategies, using both nonpharmacologic modalities such as lifestyle and rehabilitation programs, and where benefits may exist, pharmacologic therapies. There is currently no FDA-approved pharmacological treatment for addressing cognitive deficits in MS, nor is there is an optimal nonpharmacological treatment strategy. Nevertheless, it is critical that clinicians be able to integrate routine neuropsychological testing and multimodal therapies in order to design the most appropriate individual treatment for their patients with MS. In this neuroscienceCME Chart Review, expert faculty will review a patient case focusing on assessment of cognitive dysfunction and strategies for multimodal therapy, thereby providing participants with best-practice tips for application into clinical practice.
Learning Objectives:
At the end of this CE activity, participants should be able to:
- Implement tools and techniques for the assessment of cognitive dysfunction as part of daily clinical practice and in ongoing disease measurement of individual response to therapy.
- Use nonpharmacological and, where benefits may exist, pharmacological therapies to manage individual quality-of-life effects of cognitive impairment.
- Identify tools and techniques for the assessment of cognitive dysfunction as part of daily clinical practice and in ongoing disease measurement of individual response to therapy.
- Outline nonpharmacological and, where benefits may exist, pharmacological therapies to manage individual quality-of-life effects of cognitive impairment.
Physicians, physician assistants, nurses, nurse practitioners, pharmacists, and other healthcare professionals with an interest in multiple sclerosis.